BAJAJ BROKING

Notification close image
No new Notification messages
card image
Scoda Tubes IPO is Open!
Apply for the Scoda Tubes IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Tata India Pharma & Healthcare Fund (G)

Equity

Sectoral / Thematic

Calculate Your Returns

Select Duration

Total Value : ₹5,434

When you invest ₹100 over 3 years

Returns%

22.69% annually for last 3 years

Invested Gains

Similar to this Mutual Fund

Invesco India PSU Equity Fund (G)
Growth
INVEST
Min. SIP Amount
₹1,000
1Y Returns
-1.76% p.a
SBI PSU Fund (G)
Growth
INVEST
Min. SIP Amount
₹1,000
1Y Returns
-1.77% p.a
HDFC Infrastructure Fund (G)
Growth
INVEST
Min. SIP Amount
₹1,000
1Y Returns
5.62% p.a
Other Information
other info  Mobile other info
Fund Age Icon

Fund Age :

9 years

AUM Icon

AUM :

1222.72 Cr.

Lock-in Period Icon

Lock-in Period :

0

Exit Load Icon

Exit Load :

0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.

Expense Ratio Icon

Expense Ratio :

2.15% (inclusive of GST)

Tax Icon

Tax Implication

Withdrawal within 1 year:
5% tax on gains

Withdrawal after 1 year:
10% tax on gains above 21 lakh per financial year

Watch these short videos to learn more

NAV Icon
NAV Icon

NAV

Play
Tax Icon
Tax Icon

Tax

Play
Exit Load Icon
Exit Load Icon

Exit Load

Play
Expense Ratio Icon
Expense Ratio Icon

Expense Ratio

Play
Lock-in Icon
Lock-in Icon

Lock-in

Play
Fund Manager
collapse-icon mobile-collapse-icon
MS
Meeta Shetty
From Mar 2017 till date with Tata Asset Management Pvt Ltd reporting to Chief Investment Officer - Equities. Earlier she was Research Analyst, tracking Pharma, Technology and Telecom sector. Reporting to the Chief Investment Officer - Equities. From Dec 2014 to Feb 2017 with Kotak Securities, tracking Pharma sector. Reporting to the Head of Research. From Jun 2013 to Nov 2014 with HDFC Securities, as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From Sep 2011 to Jun 2013 with AMSEC (Asian Market Securities) as Research Analyst, tracking Pharma sector. Reporting to Head of Research. From May 2010 to Sep 2011 with Dalal & Broacha Stock Broking as Research Analyst, tracking Pharma sector. Reporting to Head of Research.
RS
Rajat Srivastava
From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o
Risk & Rating
risk rating  risk-rating-icons
chart
value-research
Value Research Rating
Value Research
3★
Other Funds by Tata Mutual Fund
other funds Mobile Other Funds Icons
banner-icon

Start your SIP with just ₹100

Choose from 4,000+ funds on Bajaj Broking

+91

|

Please Enter Mobile Number

Start your SIP with just ₹100

Choose from 4,000+ funds on Bajaj Broking

+91

|